MESE: Phase II study of sertraline plus cisplatin or carboplatin and pemetrexed for unresectable epithelioid pleural mesothelioma
Sponsor: Centro Di Riferimento Oncologico Di Aviano
Phase: 2
Disease: Unresectable epithelioid malignant pleural mesothelioma
EU trial number: 2026-526791-23-00
Population: Adults ≥18 years with previously untreated histologically confirmed unresectable advanced epithelioid malignant pleural mesothelioma (stage III–IV), ECOG 0–1, adequate organ function and suitability for first-line platinum-pemetrexed chemotherapy.
Register Investigator Interest
Interested in offering this trial to suitable patients?